PDS Biotechnology Corporation
PDSB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $15 |
| Gross Profit | $0 | $0 | $0 | -$15 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,576 | $4,213 | $5,831 | $4,530 |
| G&A Expenses | $0 | $3,410 | $3,275 | $0 |
| SG&A Expenses | $3,564 | $3,410 | $3,275 | $2,816 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8,140 | $7,623 | $9,106 | $7,345 |
| Operating Income | -$8,140 | -$7,623 | -$9,106 | -$7,361 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$869 | -$1,811 | -$553 | -$592 |
| Pre-Tax Income | -$9,009 | -$9,434 | -$9,659 | -$7,952 |
| Tax Expense | $0 | $0 | -$1,170 | $0 |
| Net Income | -$9,009 | -$9,434 | -$8,489 | -$7,952 |
| % Margin | – | – | – | – |
| EPS | -0.19 | -0.21 | -0.21 | -0.22 |
| % Growth | 9.5% | 0% | 4.5% | – |
| EPS Diluted | -0.19 | -0.21 | -0.21 | -0.22 |
| Weighted Avg Shares Out | 46,870 | 45,903 | 40,521 | 36,453 |
| Weighted Avg Shares Out Dil | 46,870 | 45,903 | 40,521 | 36,453 |
| Supplemental Information | – | – | – | – |
| Interest Income | $281 | $334 | $378 | $504 |
| Interest Expense | $1,150 | $2,144 | $931 | $1,096 |
| Depreciation & Amortization | $0 | $5 | $5 | $15 |
| EBITDA | -$7,859 | -$7,284 | -$8,722 | -$6,842 |
| % Margin | – | – | – | – |